BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11276396)

  • 1. RhoA/Rho-kinase, vascular changes, and hypertension.
    Chitaley K; Weber D; Webb RC
    Curr Hypertens Rep; 2001 Apr; 3(2):139-44. PubMed ID: 11276396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction.
    Swärd K; Mita M; Wilson DP; Deng JT; Susnjar M; Walsh MP
    Curr Hypertens Rep; 2003 Feb; 5(1):66-72. PubMed ID: 12530938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction.
    Sakurada S; Takuwa N; Sugimoto N; Wang Y; Seto M; Sasaki Y; Takuwa Y
    Circ Res; 2003 Sep; 93(6):548-56. PubMed ID: 12919947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction.
    Gohla A; Schultz G; Offermanns S
    Circ Res; 2000 Aug; 87(3):221-7. PubMed ID: 10926873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells.
    Ying Z; Jin L; Palmer T; Webb RC
    Mol Pharmacol; 2006 Mar; 69(3):932-40. PubMed ID: 16354763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of Rho/Rho-kinase system in regulation of vascular smooth muscle contraction in tachycardia-induced heart failure.
    Hisaoka T; Yano M; Ohkusa T; Suetsugu M; Ono K; Kohno M; Yamada J; Kobayashi S; Kohno M; Matsuzaki M
    Cardiovasc Res; 2001 Feb; 49(2):319-29. PubMed ID: 11164842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microtubule depolymerization facilitates contraction of vascular smooth muscle via increased activation of RhoA/Rho-kinase.
    Chitaley K; Webb RC
    Med Hypotheses; 2001 Mar; 56(3):381-5. PubMed ID: 11359365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.
    Xie Z; Su W; Guo Z; Pang H; Post SR; Gong MC
    Cardiovasc Res; 2006 Feb; 69(2):491-501. PubMed ID: 16336954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway.
    Bolz SS; Vogel L; Sollinger D; Derwand R; de Wit C; Loirand G; Pohl U
    Circulation; 2003 Jun; 107(24):3081-7. PubMed ID: 12796138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated RhoA/Rho-kinase activity in the aged rat penis: mechanism for age-associated erectile dysfunction.
    Jin L; Liu T; Lagoda GA; Champion HC; Bivalacqua TJ; Burnett AL
    FASEB J; 2006 Mar; 20(3):536-8. PubMed ID: 16396994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1 modulates hemoglobin-mediated signaling in cerebrovascular smooth muscle via RhoA/Rho kinase and protein kinase C.
    Lan C; Das D; Wloskowicz A; Vollrath B
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H165-73. PubMed ID: 14500131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point: release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are/are not the main effectors for full and sustained hypoxic pulmonary vasoconstriction.
    Robertson TP
    J Appl Physiol (1985); 2007 May; 102(5):2071-2; discussion 2075-6. PubMed ID: 17095630
    [No Abstract]   [Full Text] [Related]  

  • 13. Point:Counterpoint "Release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are/are not the main effectors for full and sustained hypoxic pulmonary vasoconstriction".
    Yuan JX
    J Appl Physiol (1985); 2007 May; 102(5):2078; discussion 2080. PubMed ID: 17549820
    [No Abstract]   [Full Text] [Related]  

  • 14. Point:Counterpoint: "Release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are/are not the main effectors for full and sustained hypoxic pulmonary vasoconstriction".
    Madden JA
    J Appl Physiol (1985); 2007 May; 102(5):2077; discussion 2080. PubMed ID: 17483444
    [No Abstract]   [Full Text] [Related]  

  • 15. P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes.
    Sauzeau V; Le Jeune H; Cario-Toumaniantz C; Vaillant N; Gadeau AP; Desgranges C; Scalbert E; Chardin P; Pacaud P; Loirand G
    Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H1751-61. PubMed ID: 10843869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation.
    Guilluy C; Rolli-Derkinderen M; Loufrani L; Bourgé A; Henrion D; Sabourin L; Loirand G; Pacaud P
    Circ Res; 2008 May; 102(10):1265-74. PubMed ID: 18420945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point:Counterpoint "Release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are/are not the main effectors for full and sustained hypoxic pulmonary vasoconstriction".
    Packer CS; Pelaez NJ
    J Appl Physiol (1985); 2007 May; 102(5):2078-9; discussion 2080. PubMed ID: 17549821
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute and chronic NOS inhibition enhances alpha(2)- adrenoreceptor-stimulated RhoA and Rho kinase in rat aorta.
    Carter RW; Begaye M; Kanagy NL
    Am J Physiol Heart Circ Physiol; 2002 Oct; 283(4):H1361-9. PubMed ID: 12234786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.
    Hennenberg M; Biecker E; Trebicka J; Jochem K; Zhou Q; Schmidt M; Jakobs KH; Sauerbruch T; Heller J
    Gastroenterology; 2006 Mar; 130(3):838-54. PubMed ID: 16530523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point:Counterpoint "Release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are/are not the main effectors for full and sustained hypoxic pulmonary vasoconstriction".
    Lahm T; Meldrum DR
    J Appl Physiol (1985); 2007 May; 102(5):2077-8; discussion 2080. PubMed ID: 17549819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.